Rodney Terry
Story Poster
48:13
Reasonable people: SEC's McDaid not offended by 'horns down' gesture
2 mo ago by Olin Buchanan
Texas has only been an official member of the SEC for about two weeks, but the Longhorns are a big talking point at SEC Media Days. On Tuesday, SEC Coordinator of Football Officials John McDaid indicated the Horns might not get their way regarding a particular hand gesture.
Story Poster
Storylines abound with Texas A&M basketball's 2025 SEC slate
4 mo ago by David Sandhop
On Monday afternoon, the Southeastern Conference released the league opponents for each team, with official dates and tipoffs coming at a later date. For Texas A&M, home-and-home series with Texas and Oklahoma headline an enticing 2025 conference slate.
Story Poster
A&M's Bahamas trip produced growth among returners & newcomers
1 yr ago by Olin Buchanan
Texas A&M hoops did some international traveling this summer and played three games in the Bahamas earlier this month. Speaking at The Halal Guys Showcase, associate head coach Devin Johnson expressed many reasons to be excited about the Aggies' 2023-24 squad.
Get access to all Premium content today
Start your subscription for just $1
Try Premium Now
Story Poster
67:28
Follow The Money - Ep. 41 (March MADNESS; New NCAA Prez's main role)
1 yr ago by TexAgs
In Ep. 41 of College Sports: Follow The Money, Gabe Bock, Dr. R. Bowen Loftin and Jon Heidtke dive into the absolute chaos in this year's NCAA Tournament, the hoops coaching carousel, the immediate tasks and challenges facing incoming NCAA president Charlie Baker and more.
Story Poster
16:37
Talkin' Tournament things with FOX Sports Radio's Aaron Torres
1 yr ago by David Nuño
The second weekend of the NCAA Tournament begins tonight as the Sweet Sixteen features a handful of intriguing matchups, and Aaron Torres has some thoughts. The FOX Sports Radio man took us around college sports this morning as the madness of March continues.
 
×
subscribe Verify your student status
See Subscription Benefits
Trial only available to users who have never subscribed or participated in a previous trial.